This document outlines the key steps involved in the drug discovery process:
1. Target identification involves identifying protein targets through methods like sequence analysis and cDNA library generation.
2. Target validation confirms the drug will affect the specific target through techniques like chemogenomics and target gene disruption.
3. Lead identification screens compound libraries to find leads that are potent against the target using assays.
4. Lead optimization refines the leads using computer-aided drug design and de novo drug design.
5. Preclinical pharmacology involves testing the drugs on lab animals, human cells, and clinical trials with government approval.